Preliminary results show INDs with End-of-Phase II meetings and other characteristics within a certain time period could become an NDA or BLA in 18 months. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
